JBC GenomeOne product landing page

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Tanhuanpää, K.
Right arrow Articles by Somerharju, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Tanhuanpää, K.
Right arrow Articles by Somerharju, P.

J Biol Chem, Vol. 274, Issue 50, 35359-35366, December 10, 1999


gamma -Cyclodextrins Greatly Enhance Translocation of Hydrophobic Fluorescent Phospholipids from Vesicles to Cells in Culture
IMPORTANCE OF MOLECULAR HYDROPHOBICITY IN PHOSPHOLIPID TRAFFICKING STUDIES*

Kimmo Tanhuanpää and Pentti SomerharjuDagger

From the Institute of Biomedicine, Department of Medical Chemistry, University of Helsinki, Siltavuorenpenger 10 A, 00014 Helsinki, Finland

    ABSTRACT
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Short-chain, fluorescent derivatives are commonly used to investigate intracellular phospholipid trafficking. However, their use can yield misleading results because they, unlike the native species, can rapidly distribute between organelles due to their low hydrophobicity. On the other hand, hydrophobic derivatives are very difficult to introduce to cells and thus have hardly been used. Here we show that carboxyethylated gamma -cyclodextrin (CE-gamma -CD) greatly enhances transfer of a variety of hydrophobic fluorescent phospholipid derivatives from vesicles to cultured cells. Several lines of evidence indicate that CE-gamma -CD enhances transfer of lipid molecules by increasing their effective concentration in the aqueous phase, rather than by inducing membrane fusion or hemifusion. Incubation with CE-gamma -CD and donor lipid vesicles does not extract cholesterol or phospholipids from the cells or compromise plasma membrane intactness or long term cell viability. Using CE-gamma -CD-mediated transfer, we introduced hydrophobic pyrene-labeled phosphatidylserine to the plasma membrane of fibroblast cells and followed their distribution with time. In contrast to what has been previously observed for other, less hydrophobic species, transport of this lipid to the Golgi apparatus or mitochondria was not detected. Rather, much of this fluorescent PS remained in the plasma membrane or was incorporated to various endocytotic compartments. These findings indicate that the native, typically hydrophobic phosphatidylserine molecules efflux only very slowly via the cytoplasm to intracellular organelles. This helps to explain how cells can maintain a very high concentration of phosphatidylserine in the inner leaflet of their plasma membrane. Furthermore, the present results underline the importance of using hydrophobic analogues when studying intracellular trafficking of many phospholipid classes.

    INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

In eukaryotic cells, most phospholipids are synthesized in the endoplasmic reticulum but are abundant in all organelle membranes (1). Accordingly, efficient transport of those phospholipids from the endoplasmic reticulum to the other organelles must take place. There are several mechanisms that could accomplish this transfer, i.e. vesicle traffic, spontaneous or protein-assisted diffusion via the cytoplasm, or diffusion via membrane fusion (or hemifusion) sites (reviewed in Refs. 2 and 3). However, the involvement and relative contributions of these various transport mechanisms have not been established. It is also unknown how intracellular trafficking of phospholipids is controlled so that the different membranes can maintain their distinct lipid compositions. A major reason for the lack of this crucial information is largely a technical one: there are no simple and efficient methods to trace movements and distributions of phospholipids inside the cell. For instance, immunolocalization, which has played the key role in resolving the transport mechanism and sorting of proteins, cannot be applied, as (i) phospholipids are generally poor antigens, (ii) most phospholipids are abundant in all membranes and thus there is no adequate concentration gradient, and (iii) it is not possible to obtain stoichiometric complex formation due to the large size of the antibody molecule.

To circumvent the tracing problem, short-chain fluorescent (NBD6) lipids were introduced to this field by Pagano and co-workers (reviewed in Refs. 4 and 5). Although such derivatives have proven to be very useful to study sphingolipid trafficking (6, 7), they have been less successful when glycerophospholipid transport is being investigated. One reason for this is that short chain NBD6-phospholipids are rapidly degraded (half-life is 1 h or less) in mammalian cells at the physiological temperature (8-10). The altered conformation of such lipids (11, 12) may render them targets for some cellular phospholipases. However, an even more serious limitation is that the short chain lipids, unlike the natural ones, can distribute spontaneously between all accessible membrane surfaces due to their hydrophilicity (8). Thus, their use is very problematic when one studies intracellular trafficking of lipids having access to the cytoplasmic leaflet of organelle membranes, which is the case with most glycerophospholipids. Accordingly, fluorescent derivatives with hydrophobicity similar to that of endogenous phospholipids need to be employed to obtain relevant information on intracellular trafficking of the latter. Unfortunately, such derivatives are difficult to introduce into cells just because of their hydrophobicity. Although several methods allowing introduction of hydrophobic fluorescent lipids to cells have been reported (13), none of them has gained significant popularity, for various reasons.

Recently, beta -cyclodextrin derivatives were shown to mediate efficient transfer of cholesterol between lipid vesicles and cells in culture (14, 15). This led us to examine whether some cyclodextrins could be used to introduce hydrophobic fluorescent phospholipid derivatives into cultured cells. Primarily pyrene-labeled phospholipids were employed in these studies because several systematically constructed sets were available (16, 17), which helps to draw conclusions regarding the mechanism of lipid transfer (18). The pyrenyl derivatives are also attractive because they, in all respects studied so far, behave similarly to natural lipids (16, 17, 19) and should allow one to map microscopically lipid concentration gradients in cellular membranes (20). Additional studies were carried out with Bodipy-labeled derivatives, because they offer some advantages over the pyrene derivatives.

    EXPERIMENTAL PROCEDURES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Lipids and Other Reagents-- All unlabeled lipids were obtained from Avanti Polar Lipids (Alabaster, AL). Bodipy12-PC,1 -PE, and -SM, as well as NBD12PC, were supplied by Molecular Probes Europe (Leiden, Netherlands). Bodipy-PC and -PE were repurified shortly before use by HPLC on silica gel and Bodipy-SM on a reverse phase column. Typically, such repurification greatly reduced labeling of cells in the absence of cyclodextrin by removing free fatty acid and/or other impurities. The pyrenylacyl glycerophospholipids were synthesized as described previously (21, 22). Pyrenyldecanoyl sphingomyelin was synthesized using the method of Via et al. (23) and purified by HPLC on a silica column using a chloroform/methanol gradient and then further purified on an octadecylsilica column. [3H]Cholesterol oleate was synthesized as described previously (24). All labeled lipids were at least 99.5% pure as determined by HPLC. The cyclodextrins were obtained from Cyclolab (Budapest, Hungary). The cell culture media were obtained from Life Technologies, Inc., and all other chemicals were from Sigma.

Assays for Cyclodextrin-mediated Lipid Transfer and Binding-- The previously described assays (16) were employed to study the transfer and binding of pyrenyl lipids. The donor vesicles consisted of a pyrenyl lipid, POPC, and TNP-PE (0.2:45:5 nmol), whereas the acceptor vesicles consisted of POPC and POPA (480:20 nmol). Transfer of the pyrenyl lipid molecules from quenched donor vesicles to acceptor vesicles results in de-quenching of pyrene fluorescence, which is recorded. The initial slope of the progress curve is used as the measure of transfer rate. To measure binding, donor vesicles were titrated with a cyclodextrin solution, and the pyrene fluorescence intensity was recorded. Fluorescence measurements were carried out using either a Hitachi F-4000 or PTI QuantaMaster spectrofluorometer equipped with a thermostatted cuvette holder. The excitation and emission wavelengths were 345 and 395 nm for pyrene and 480 and 520 nm for Bodipy, respectively. All measurements were carried out at 25 °C.

Cell Culture-- Normal Human fibroblasts (GM08333) and BHK-21 cells were grown as before (18, 25). For microscopy, the cells were plated on round 32-mm coverslips placed in home-built aluminum-Teflon chambers. Before use, the coverslips had been cleaned by treating them for 1 h at 50 °C with 1 M NaOH and 1 M HCl each, followed by washing with water and ethanol. After 1-2 h of incubation at 37 °C, the inoculum was removed, and the attached cells were washed, covered with normal growth medium, and placed in the incubator. Labeling and imaging were carried out the following day. This cultivation protocol considerably reduced the amount of cell debris on the coverslips.

Incubation of cells with cyclodextrins and donor vesicles-- Cell monolayers were washed twice with CO2-independent minimal medium (I-MEM), twice with phosphate-buffered saline and then incubated at room temperature or 37 °C in I-MEM containing the donor vesicles with or without cyclodextrin. The donor vesicle compositions are specified under "Results." The CE-gamma -CD stock solution was prepared in I-MEM and adjusted to pH 7.4 to avoid acidification of the incubation medium. This adjustment somewhat reduced the efficiency of labeling but was necessary to avoid harmful effects to cells, particularly at higher CE-gamma -CD concentrations. After the incubation, the cells were washed three times with I-MEM and then subjected to imaging or lipid extraction. For the latter, the cells were scraped into phosphate-buffered saline, washed twice by centrifugation, and then extracted according to Ref. 26. The amount of cell-associated fluorescent lipid was determined by measuring the pyrene (excimer) or Bodipy fluorescence intensity of the extract. Extracts of nonincubated cells were used as blanks. Alternatively, the amount of cell-associated fluorescent lipid was determined by HPLC analysis using on-line fluorescence detection (27). For quantification, an internal standard (a Bodipy or pyrene lipid, as appropriate) was added to the cell pellet before the extraction. To determine vesicle binding to cells, [3H]cholesterol oleate (50,000 cpm/dish) was included in the donor vesicles.

Fluorescence Imaging-- After washing, the cells on coverslips were covered with I-MEM containing glucose, glucose-oxidase, and catalase to deplete oxygen from the medium (28). Oxygen depletion virtually eliminates photobleaching of the pyrene chromophore but has no detectable effect on fluorophore distribution or cell morphology (25). Imaging was carried out on a Zeiss Axiovert 10 microscope equipped with a cooled CCD camera as detailed (25). For pyrene lipids, a 340 nm (BP, 11 nm) excitation filter, a 480 nm (BP, 80 nm) emission filter, and a 375 nm dichroic mirror were used. The images were corrected for background fluorescence and scatter by subtracting a background image obtained with a 360 nm (BP, 5 nm) excitation filter and multiplied with an empirically determined factor. As will be shown elsewhere,2 pyrene is not significantly excited with the 360 nm filter, whereas the background fluorescence/scatter is excited similarly with the 360 and 340 nm filters. A particularly useful feature of this type of background correction is that it properly accounts for the typically uneven distribution of cellular autofluorescence. With the Bodipy lipids 480 nm (BP, 30 nm) and 535 nm (BP, 40 nm) excitation and emission filters were used, respectively.

Other Methods-- Lactate dehydrogenase was determined essentially as described (29). Concentrations of unlabeled phospholipids were determined by a phosphate assay (30) and protein concentrations by a fluorescamine assay (31).

    RESULTS
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

CE-gamma -CD Greatly Enhances Transfer of Phospholipid Molecules between Vesicles-- To test the ability of cyclodextrin derivatives to enhance intermembrane phospholipid transport, we employed a previously developed fluorescence assay (16). In this assay, the donor vesicles contain the pyrene lipid under study, TNP-PE, a quencher of pyrene fluorescence, and unlabeled phospholipids, whereas the acceptor vesicles consist of unlabeled lipids only. Transfer of the pyrene lipid molecules from the donor to the acceptor vesicles results in dequenching of pyrene fluorescence, which was recorded. Fig. 1 displays the result of an assay in which transfer of 16:0/Pyr10PC was studied. When the donors were incubated with the acceptor vesicles only, a very slow increase of pyrene fluorescence was observed (Fig. 1, curve a), indicating that the spontaneous transfer of this particular pyrene lipid is a very slow process. Upon addition of 30 mM CE-gamma -CD, a remarkable (~350-fold) increase in the rate of fluorescence enhancement was observed (curve b), indicating that CE-gamma -CD greatly accelerates intervesicle translocation of Pyr10PC. As shown in the inset of Fig. 1, the rate of transport is closely proportional to CE-gamma -CD concentration. Parallel experiments were carried out with a variety of other cyclodextrin derivatives, but none of them proved to be as efficient as CE-gamma -CD (data not shown). Because CE-gamma -CD also remarkably enhanced intervesicle transfer of other pyrenyl phospholipids as well as those labeled with the NBD12 or Bodipy12 fatty acids (not shown, but see below), CE-gamma -CD was chosen for further experiments.


View larger version (13K):
[in this window]
[in a new window]
 
Fig. 1.   CE-gamma -CD greatly enhances transfer of Pyr10PC from donor to acceptor vesicles. Donor vesicles consisting of Pyr10PC/POPC/POPA/TNP-PE (0.2:45:5:5 nmol) were incubated with POPC/POPA (500:20 nmol) acceptor vesicles in the absence (curve a) of presence (curve b) of 30 mM CE-gamma -CD. CE was added after 1.5 min of incubation. Inset, effect of CE-gamma -CD concentration on the initial rate of transfer.

CE-gamma -CD-mediated Transfer Is Strongly Dependent on Pyrene Lipid Hydrophobicity-- To obtain information on the mechanism of cyclodextrin-mediated phospholipid transfer, the effect of the length of the pyrene-labeled acyl chain (6-14 carbons) on the rate of CE-gamma -CD mediated transfer was investigated. As displayed in Fig. 2, the rate decreases strongly (exponentially) with increasing length of the pyrene-labeled chain. Analogous results were obtained for lipids that contained two pyrene-labeled chains of identical length (n = 6-14; data not shown, but see below). Such strong chain length dependence of the rate of fluorescence increase (probe dilution) clearly indicates that CE-gamma -CD enhances monomeric transport of the labeled lipid molecules, rather than causes fusion or hemifusion between the donor and acceptor vesicles. If either of the latter mechanisms were to dominate, the rate of fluorescence increase would be independent of the chain length of the pyrene phospholipid, which clearly is not the case. In addition, the fact that hardly any increase of fluorescence was observed for the pyrene PC with longest chain (see Fig. 2) excludes the possibility that transfer of the quencher molecules, if occurring, would significantly contribute to the observed enhancement of pyrene fluorescence in this assay.


View larger version (8K):
[in this window]
[in a new window]
 
Fig. 2.   CE-gamma -CD-mediated transfer PyrnPC species decreases systematically with increasing acyl chain length (hydrophobicity). The transfer assay was carried out as detailed in the legend to Fig. 1. The length of the pyrene-labeled acyl chain was varied from 6 to 14 carbons. The concentration of CE-gamma -CD was 5 mM. The data are averages of three independent experiments. The spontaneous rate, which was maximally 1.3% of the CE-gamma -CD-mediated rate, has been subtracted.

To study the mechanism of CE-gamma -CD mediated pyrene phospholipid transfer, quenched donor vesicles containing Pyr10PC were titrated with CE-gamma -CD, and the pyrene emission spectrum was recorded. The spectral intensity increased strongly upon addition of CE-gamma -CD, and the increase was proportional to the amount of CE-gamma -CD added (data not shown). Parallel results were obtained for the other PyrnPCs and DiPyrnPCs tested. These results are analogous to those obtained previously for phospholipid carrier proteins (16, 17) and therefore strongly suggest that CE-gamma -CD forms of soluble complexes with pyrene phospholipids in the aqueous phase, thereby enhancing their translocation between vesicles (see under "Discussion").

Effect of the Lipid Head Group and Backbone Structure on the Rate of CE-gamma -CD-mediated Transport-- We also studied the effect of the head group on the rate of cyclodextrin-enhanced transfer of pyrene-labeled phospholipids (Fig. 3). Among glycerophospholipids, transfer of phosphatidylglycerol, PE, PS, and PC is similarly enhanced, whereas that of phosphatidylinositol is enhanced about twice as much by 5 mM CE-gamma -CD. This more rapid transfer of phosphatidylinositol is probably due to the considerable polarity of the head group. Supporting this, transfer of diglyceride, which has a very small polar moiety, is much less efficient than that of the phospholipids. Notably, Pyr10SM is transported almost 3 times more rapidly than Pyr10PC. The additional hydroxyl group and double bond in the sphingosine moiety obviously makes SM somewhat less hydrophobic than PC with similar acyl chains. We conclude that the overall molecular hydrophobicity, rather than some structural details, determines the rate of CE-gamma -CD-mediated transport of the pyrenyl lipids.


View larger version (18K):
[in this window]
[in a new window]
 
Fig. 3.   Effect of the lipid head group on the transfer of monopyrenyl lipids by CE-gamma -CD. The initial rate of transfer was determined as detailed in the legend to Fig. 1. The donor vesicles consisted of a Pyr10-lipid/TNP-PE/POPC (0.2:5:45 nmol)

CE-gamma -CD Also Greatly Enhances Transfer of Hydrophobic Fluorescent Lipids from Vesicles to Cultured Cells-- Having shown that CE-gamma -CD mediates efficient transport of fluorescent phospholipids between phospholipid vesicles in vitro, we next studied whether these compounds also catalyze transport of fluorescent phospholipids from vesicles to cells in culture. To this end, vesicles containing a pyrene- or Bodipy-labeled phospholipid were incubated with cell monolayers at room temperature or 37 °C, and after washing, the amount of cell-associated fluorescent lipid was determined using either fluorescence imaging or spectroscopy.

For imaging studies, we employed dipyrenyl phospholipids, i.e. species containing two pyrene-labeled chains, because such species display strong excimer fluorescence (peak at 480 nm) due to frequent interpyrene collisions (32). This excimer fluorescence is more readily visualized with our imaging system than the monomer fluorescence (peaks at 378 and 395 nm) that the monopyrenyl lipids mainly emit. Furthermore, the wide separation of the excitation (345 nm) and emission peaks avoids excitation/emission crossover, as well as allowing efficient correction for background fluorescence as described under "Experimental Procedures." Yet another important advantage of the dipyrenyl derivatives is that the (possible) presence of fatty acid and/or lysolipid impurities in the donor vesicles does not interfere with interpretation of the images, because these compounds do not display detectable excimer fluorescence under the conditions used. Presence of even minor amounts (<1%) of fluorescent fatty acid or lysolipid could lead to artifactual results due to their very rapid spontaneous transfer (33) as compared with the intact phospholipid. Such selective imaging of the intact phospholipid is obviously not possible with the monopyrenyl or Bodipy derivatives.

Fig. 4 shows human fibroblast cells incubated for 15 min at 37 °C with donor vesicles containing DiPyr10PC in the presence or absence of 30 mM CE-gamma -CD. Clearly visible excimer fluorescence, mainly on the plasma membrane, was observed in the presence of CE-gamma -CD (Fig. 4a), whereas practically none was detectable in its absence (Fig. 4b). Parallel results were obtained for DiPyr10PS (Fig. 4, c and d). Very similar labeling efficiencies were obtained when the incubation was carried at 25 °C for 30 min, whereas less efficient or marginal labeling was observed when the incubation was carried out for 30 min at 18 or 10 °C, respectively (data not shown). CE-gamma -CD also strongly enhanced transfer of the Bodipy-derivatives from the donor vesicles to cells, as shown for Bodipy-SM in Fig. 4, e and f. However, significant labeling of cells by Bodipy-SM (and other Bodipy derivatives) occurred even in the absence of cyclodextrin, apparently because of the relatively low hydrophobicity of the Bodipy derivatives (see below). This is not clearly shown by Fig. 4f because of the lower concentration of Bodipy12-SM donor vesicles used (see legend to Fig. 4).


View larger version (85K):
[in this window]
[in a new window]
 
Fig. 4.   CE-gamma -CE greatly enhances transfer of fluorescent phospholipids from donor vesicles to cells. Monolayers of human fibroblasts on coverslips were incubated with donor vesicles consisting of DiPyr10PC/POPC/POPA/TNP-PE (20:170:10:20 nmol) (a and b), DiPyr10PS/POPC//TNP-PE (20:170:20 nmol; c, d) or Bodipy-SM/POPC/POPA (1:4.75:0.25 nmol) (e and f) in I-MEM for 30 min at 25 °C, washed, covered with fresh I-MEM containing oxygen depletion reagents, and imaged as detailed under "Experimental Procedures." In a and c, 30 mM CE-gamma -CD and in e 5 mM CE-gamma -CD was present during incubation, whereas CE-gamma -CD was omitted in b, d, and f. The camera settings and image adjustments were identical in each case. The insets display the original images with the pixel intensities multiplied by a factor of 20. Many of the brightest structures visible in the insets are cell debris (see legend to Fig. 5). Note that much less Bodipy12-SM than DiPyrnPCs was used.

We then carried out analogous labeling experiments with other DiPyrnPC species in order to establish the limits of the method, as well as to confirm that the enhanced labeling in the presence of cyclodextrin is due to monomeric transfer of the fluorescent lipid rather than due to fusion or adherence/endocytosis of the donor vesicles. The results are summarized in Fig. 5. As expected, most efficient CE-gamma -CD-mediated labeling was obtained with DiPyr6PC (Fig. 5a). The efficiency decreased systematically with increasing length of the acyl chains, and with DiPyr14PC, virtually no labeling was observed (Fig. 5i). For DiPyr6PC and DiPyr8PC, significant labeling was also observed in the absence of CE-gamma -CD (Fig. 5, b and d), but not for the long chain derivatives (Fig. 5, f, h, and j). Notably, the fact that practically no labeling with the most hydrophobic pyrene lipids was observed in the presence of CE-gamma -CD provides strong evidence that CE-gamma -CD enhances monomeric transfer of the pyrene derivatives, rather than inducing vesicle-cell fusion, adherence, or endocytotic uptake of vesicles. These data also show that DiPyr10PC is the most hydrophobic dipyrenyl derivative for which adequate levels of labeling were achieved under the present labeling conditions.


View larger version (53K):
[in this window]
[in a new window]
 
Fig. 5.   CE-gamma -CD-mediated cell labeling diminishes systematically with increasing hydrophobicity of DiPyrnPC. Fibroblast monolayers on coverslips were incubated with donor vesicles consisting of DiPyrnPC/POPC/POPA/TNP-PE (20:170:10:20 nmol) in I-MEM at 37 °C for 15 min, washed, and imaged. DiPyrnPCs used were as follows: DiPyr6PC (a and b), DiPyr8PC (c and d), DiPyr10PC (e and f), DiPyr12PC (g and h), and DiPyr14PC (i and j). In a, c, e, g, and i, CE-gamma -CD (15 mM) was present, whereas it was omitted in b, d, f, h, and j. The camera settings and image adjustments were identical in each case. The brightly fluorescent structures often seen to attach to cells or matrix, in both the presence and the absence of cyclodextrin (white arrows in a and e), consist of cell debris. Presumably, debris may become strongly labeled either because the PyrnPC monomers more readily integrate to the less tightly packed (due to degradation) membranes and/or because donor vesicles readily fuse with the membrane remnants of the debris.

Although the dipyrenyl lipids used here were of high purity, the fraction of the long-chain dipyrenyl lipids, such as DiPyr10PC, transferred from the donor vesicles to cells is rather small (see below). Therefore, it was considered necessary to exclude the possibility that some, or even all, of the cell-associated excimer fluorescence would derive from pyrene fatty acid/lysolipid impurities rather than from intact DiPyr10PC. To accomplish this, human fibroblast cells were incubated with donor vesicles containing up to 1 nmol of Pyr10-fatty acid (which corresponds to 5% fatty acid impurity in DiPyr10PC, i.e. far more than could be present; see under "Experimental Procedures") in the presence of 15 mM CE-gamma -CD. No pyrene excimer fluorescence could be detected in the cells (data not shown), thus demonstrating that the pyrene fluorescence observed in cells incubated with DiPyr10PC and CE-gamma -CD derives from intact lipids rather than from possible impurities.

To confirm that CE-gamma -CD indeed mediates monomeric transfer of the fluorescent lipids rather than causing fusion or association of the donor vesicles with the cells, BHK cell monolayers were incubated with donor vesicles containing a fluorescent lipid and [3H]cholesterol oleate, a nontransferable liposomal marker, in the presence of 0-30 mM CE-gamma -CD for 30 min at room temperature. Fig. 6a shows results for Bodipy-SM. The amount of cell-associated Bodipy-SM increased strongly with the CE-gamma -CD concentration up to 15 mM CE-gamma -CD. At this concentration, about 5% of the liposomal Bodipy-SM has become cell-associated. In contrast, only about 0.3% of the [3H]cholesterol ester, the liposomal marker, was associated with the cells independent of the CE-gamma -CD concentration used. Parallel results were obtained for DiPyr6PC except that somewhat less fluorescent PC was transferred to the cells (Fig. 6b). These data are consistent with the proposition that CE-gamma -CD enhances monomeric transport of the fluorescent phospholipids from donor vesicles to cells. We also carried out analogous experiments with DiPyr10PC but could not obtain conclusive data, probably because the fraction of this (much more hydrophobic) lipid (see below) transferred to cells is quite small and comparable to the fraction of vesicles adhering to cells or cell-associated debris. Nevertheless, the imaging data in Fig. 5 clearly indicate that CE-gamma -CD indeed mediates monomeric transfer of DiPyr10PC as well.


View larger version (11K):
[in this window]
[in a new window]
 
Fig. 6.   CE-gamma -CD enhances monomeric transfer of fluorescent phospholipids to cells rather than vesicle fusion or adhesion. (a) BHK cell monolayers were incubated in I-MEM containing donor vesicles consisting of Bodipy-SM, POPC, TNP-PE and POPA (5:42.5:5:2.5 nmol) and [3H]cholesterol oleate (50,000 cpm) in the presence of indicated amounts of CE-gamma -CD for 15 min at 37 °C. After washing, the cells were scraped off, extracted and the amount of Bodipy-SM (open symbols) and 3H radioactivity (closed symbols) were determined by fluorescence spectroscopy and liquid-scintillation counting, respectively. b, as in a, but the donor vesicles contained DiPyr6PC instead of Bodipy-SM. The data are means of two parallel dishes, and the error bars indicate the difference from the mean. Analogous results were obtained in similar experiments in which the amount of the fluorescent lipid was determined by an HPLC assay (see "Experimental Procedures").

Spontaneous Transfer of Long Chain Pyrenyl Lipids Is Similar to That of Typical Natural Species-- To compare the spontaneous transfer rate of the fluorescent analogues with that of natural phospholipid species, we used a simple reverse-phase HPLC assay. Previous studies have shown that there is a close correlation between the rate of spontaneous transfer of a lipid and its retention time on a reverse-phase column (34). Although such a correlation is strictly valid only for members of a homologue series, reasonable estimates should be obtained using this method. Accordingly, we determined the retention times for different fluorescent PCs as well as for some common natural species and calculated the relative rates of spontaneous transfer. The results are shown in Table I. Notably, the predicted rates for Pyr10PC and DiPyr10PC are similar to that of 16:0/18:1 and significantly slower than that of two other common natural species, 16:0/20:4-PC and 18:0/20:4-PC. The rate predicted for DiPyr8PC is higher than that for 18:2/18:2-PC but lower than that for 18:3/18:3-PC. In contrast, DiPyr4PC, DiPyr6PC, Bodipy12-PC, and NBD12-PC are predicted to transfer far more rapidly than any of these natural species.

                              
View this table:
[in this window]
[in a new window]
 
Table I
Predicted spontaneous transfer rates of fluorescent and natural phospholipid species
Retention times and predicted transfer rates are shown only for PC species, but the (relative) values would be identical for PS and other phospholipids.

To estimate the validity of these predictions, we determined the rate of Pyr10PC directly using the assay shown in Fig. 1. The half-time of transfer was found to be 74 h at 25 °C as determined from a progress curve recorded over 48 h. This agrees well with the value of 36 h obtained previously for Pyr10PC at 37 °C (35). In comparison, a half time of 48 h has been obtained for 16:0/18:1-PC at 37 °C (36). Thus, the rate of spontaneous transfer of Pyr10PC (and probably that of DiPyr10PC as well) is indeed similar to that of 16:0/18:1-PC, as was predicted based on the retention time data (Table I).

Incubation with CE-gamma -CD Does Not Compromise Plasma Membrane Intactness or Cell Viability-- To study whether the labeling protocol perturbs the integrity of the plasma membrane, BHK cell monolayers were incubated with donor vesicles containing DiPyr10PC and 30 mM CE-gamma -CD either for 30 min at 25 °C or for 15 min at 37 °C, and the activity of the cytosolic enzyme lactate dehydrogenase in the medium was determined. Under these conditions, 0.4 ± 0.15 or 1.3 ± 0.35% (n = 4) of the total cellular lactate dehydrogenase was found in the medium, respectively. For the control cells, incubated similarly but in the absence of CE-gamma -CD, the values were 0.5 ± 0.19 and 1.3 ± 0.24% (n = 4), respectively. Thus incubation with the cyclodextrin does not seem to compromise the integrity of the cell membrane significantly. Supporting this conclusion, visual inspections of treated and control cells revealed no obvious differences in trypan blue penetration.

To investigate the effect of the labeling procedure on long-term cell viability, sparse (approximately 15% confluent) BHK cell monolayers were subjected to labeling for 30 min at 25 °C and then incubated for several days in the normal growth medium. In cyclodextrin-treated cultures, the amount of cell protein increased from the prelabeling value of 0.4 ± 0.1 mg to 3.5 ± 0.3 mg and in control cultures to 3.4 ± 0.4 mg (n = 6). Hence, the labeling procedure does not seem to affect the long term viability of the cells either.

CE-gamma -CD Does Not Seem to Extract Phospholipids or Cholesterol from the Cells-- To study whether incubation of with CE-gamma -CD and donor vesicles alters the phospholipid composition of the cells, mass spectroscopic measurements (37, 38) of the medium and the cells were carried out. Because it is likely that phospholipids in the outer leaflet of the plasma membrane would be preferentially extracted, the analyses were focused on PC, SM, and PE, which together represent nearly 100% of the outer leaflet phospholipids in BHK cells (39). Unfortunately, the phospholipid composition of the labeling medium could not be determined because of some compounds present interfered with the mass spectroscopic analysis. Analysis of the cells did not reveal significant differences between those labeled and controls, except that the former contained somewhat more 16:0/18:1-PC. However, the increase of 16:0/18:1-PC was quite variable, and further experiments (data not shown) indicated that this extra 16:0/18:1-PC is not truly incorporated to cell membranes, but probably derives from donor vesicles adhering to the cells or cell debris. Notably, the analysis of the total cellular lipid composition do not exclude the possibility that some changes in the lipid composition of the plasma membrane outer monolayer in fact occurs, because this compartment contains only a fairly small fraction (13%) (39) of the total cellular phospholipid.

Previous studies have shown that gamma -cyclodextrin does not extract phospholipids efficiently from erythrocytes, whereas the alpha -derivative does (40). The larger hydrophobic cavity of gamma -cyclodextrins apparently favors complex formation with fluorescent lipids having bulky groups in the acyl chain(s) but disfavors complexation of phospholipids with natural acyl chains.

Certain cyclodextrins extract cholesterol efficiently from cells (14, 40), which may compromise cell viability or alter cellular metabolism (41, 42). To study whether such cholesterol depletion also occurs under present conditions, we incubated BHK cells with DiPyr10PC containing donor vesicles in the presence or absence of 30 mM CE-gamma -CD for 30 min at 25 °C and then determined the cholesterol content of the cells. The cells incubated with CE-gamma -CD contained 22 ± 3.4 nmol of cholesterol/dish (n = 3), whereas the controls contained 24 ± 5. nmol/dish (n = 4). Hence, the labeling procedure does not cause significant depletion of cellular cholesterol. This, together with the lack of significant extraction of phospholipids, probably explains why the intactness of the cell membrane is maintained under the labeling condition employed.

Fluorescent Lipids Are Deposited Initially to the Outer Leaflet of the Plasma Membrane-- To confirm that the CE-gamma -CD-mediated cell labeling is indeed due to (initial) incorporation of the fluorescent lipid monomers to the outer leaflet of the cells, we labeled BHK cells with DiPyr8PC and -PS as above and then followed the distribution of these lipids during a chase at 37 °C using fluorescence imaging. DiPyr8-derivatives were used here because they can distribute more readily among accessible membranes than the much more hydrophobic DiPyr10-derivatives (see below). Fig. 7a shows BHK cells labeled with DiPyr8PC and then chased for 5 h at 37 °C. As compared with situation before the chase (Fig. 5c), the plasma membrane fluorescence was strongly diminished, whereas there was a marked increase in the labeling of intracellular structures, including punctate pericellular and more diffuse perinuclear structures, which may represent secondary endosomes and the endosytic recycling compartment, respectively (43). On the other hand, no obvious labeling of the mitochondria or the nuclear membrane was apparent. Parallel results were obtained with DiPyr6PC (see below) and with DiPyr4PC previously (25). These findings indicate that dipyrenyl PCs are initially introduced as monomers to the outer leaflet of the plasma membrane and later incorporate to endosomes and related organelles. If fusion of the vesicles with cell membrane had occurred, labeling of the mitochondria and the nuclear membrane would be expected (see below and cf. Ref. 4).


View larger version (96K):
[in this window]
[in a new window]
 
Fig. 7.   Distinct modes of labeling are observed for DiPyr8PC and -PS after chasing at 37 °C. BHK cells on coverslips were incubated with donor vesicles containing DiPyr8PC (a) or DiPyr8PS (b) for 15 min at 37 °C, washed, and then chased for 5 h in the growth medium before imaging. In the cells labeled with DiPyr8PC, vesicular structures, probably endosomes, are typically most strongly labeled, whereas DiPyr8PS labels mitochondria (arrows) prominently.

In contrast, when BHK cells were labeled with DiPyr8PS for 15 min at 37 °C and then chased for 5 h at 37 °C, prominent labeling of mitochondria was observed (Fig. 7b). Labeling of these organelles is in agreement with previous data obtained for NBD6PS (44), NBD12PS (45), and DiPyr4PS (25) and can be explained as follows. The PS molecules are initially introduced to the outer leaflet of the plasma membrane, but they move rapidly to the inner leaflet with the assistance of the aminophospholipid translocase (46). From the inner leaflet, the fluorescent PS molecules move further, possibly via spontaneous diffusion (see below), to various organelles, including mitochondria, where they can be decarboxylated to PE (45, 47). We conclude that the intracellular distribution modes of DiPyr8PC and -PS are compatible with the proposition that CE-gamma -CD mediates monomeric incorporation of the fluorescent lipids initially to the outer leaflet of the plasma membrane, rather than inducing fusion or endocytosis of the donor vesicles.

Hydrophobic Dipyrenyl PS Is Not Transported Efficiently from the Plasma Membrane to Mitochondria-- Because DiPyr8PS and other fluorescent derivatives used previously (see above) are much less hydrophobic (cf. Table I) than typical native PS species (mostly 16:0/18:1 in BHK cells) (18), it was of interest to determine whether more hydrophobic dipyrenyl PS species, also, would be transported from plasma membrane to mitochondria. DiPyr10PS, the predicted spontaneous transfer rate of which is more than 10 times slower than that of DiPyr8PS (Table I), was introduced to BHK cells, and the cells were chased in normal medium for up to 23 h. The results are summarized in Fig. 8. After a 30-min chase, the plasma membrane was the most prominently labeled structure, as expected (Fig. 8a), but some labeling of intracellular structures was also obvious. After 3 h (Fig. 8b), the juxtanuclear region, possibly the endosomal recycling compartment (cf. Ref. 43) was prominently labeled, along with the plasma membrane. At 5 h (Fig. 8c), probe distribution remained similar, except that juxtanuclear labeling was somewhat diminished, and punctate fluorescence, presumably representing secondary endosomes, was observed. After 23 h of chase (Fig. 8d), the overall fluorescence intensity was somewhat diminished, and in most cells, the punctate structures were more prominent than before. Notably, in none of these images is there any indication that DiPyr10PS would be present in mitochondria. This is in striking contrast with what was observed here for DiPyr8PS (Fig. 7b) and previously for DiPyr4PS and NBD12PS (25, 45), thus strongly suggesting that native plasma membrane PS, probably consisting mainly of hydrophobic species (see under "Discussion"), moves only very slowly, if at all, to these organelles.


View larger version (41K):
[in this window]
[in a new window]
 
Fig. 8.   DiPyr10PS is not transported effectively to mitochondria. BHK cells growing on coverslips were incubated with donor vesicles containing DiPyr10PS for 30 min at 37 °C, washed, and then further incubated for 0.5 (a), 3 (b), 5 (c), or 23 (d) h in the growth medium before imaging. It appears as if the total fluorescence intensity of cells increases from 30 min to 3 h of chase. This increase is probably an imaging artifact resulting from accumulation of fluorescent lipids to the central, thicker regions of the cells. Due to significant contribution by out of focus levels, the observed intensity appears to be higher than when the fluorescent molecules are more evenly distributed within the cell.


    DISCUSSION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

CE-gamma -CD Mediates Efficient Intermembrane Transfer of Hydrophobic Fluorescent Phospholipids-- The present study demonstrates that CE-gamma -CD greatly accelerates translocation of hydrophobic pyrene-labeled phospholipids between vesicles, as well as from vesicles to cells (Fig. 4). Also, the transfer of Bodipy12- and NBD12-phospholipids was remarkably enhanced by CE-gamma -CD, thus demonstrating that we are not dealing with a phenomenon unique for the pyrene derivatives. Several lines of evidence (see under "Results") indicate that CE-gamma -CD enhances monomeric transfer of phospholipid molecules, rather than inducing membrane fusion or hemifusion. It is not clear from the present experiments what the precise mechanism of this monomeric transfer is. One obvious possibility is that CE-gamma -CD forms soluble complexes with the lipid molecule once it has fully or partially effluxed from the donor membrane surface and then carries the complexed lipid to the acceptor membrane. Several CE-gamma -CD molecules in turn could act as carriers (a "relay" mechanism). The alternative, perhaps less probable mechanism is that CE-gamma -CD increases the concentration of free phospholipid monomers in the aqueous phase by forming transient complexes close to the donor surface. Previous studies have established that the rate of (spontaneous) transfer of phospholipids between membranes is proportional to the free monomer concentration (48-50).

Intracellular Distribution of Hydrophobic Pyrene PS Indicates Slow Efflux of Native Plasma Membrane PS Species to Intracellular Organelles-- PS makes up as much as one-third of the phospholipids in the inner leaflet of the mammalian cell plasma membrane (39). A high concentration of PS may be required to support various crucial processes, such as fusion of exosome with the plasma membrane or the protein kinase C reaction. It is totally unclear how the cell can maintain so high a concentration of PS in the inner leaflet of the plasma membrane. One possibility is that the plasma membrane PS consists predominantly of saturated, hydrophobic species, as indicated by the study of Keenan and Morre (51). Enrichment of hydrophobic species in the plasma membrane could result from selective depletion of the hydrophilic species due their facile transport to mitochondria and decarboxylation therein, after the synthesis in the endoplasmic reticulum (18). In addition, hydrophobic PS species could have a higher affinity for lipid "rafts" that are targeted to the plasma membrane (52). Once they have reached the plasma membrane, they would be prevented from "leaking" to other organelles due to their very slow spontaneous diffusion (see below). On the other hand, the hydrophobic plasma membrane PS molecules are likely to incorporate into endosytic vesicles and subsequently in other endosomal compartments. Our present results strongly support this model by showing that the hydrophobic fluorescent derivative, DiPyr10PS, is present in the plasma membrane and in various endocytic compartments but apparently not in the Golgi apparatus or mitochondria (Fig. 8). However, further studies are needed to determine whether DiPyr10PS correctly reports on intracellular trafficking of natural plasma membrane PS species.

Previously, NBD12PS has been shown to move quite rapidly from the plasma membrane to the Golgi apparatus and mitochondria (45). Because the authors considered this fluorescent species as being "relatively nonexchangeable," and because inhibition of vesicular transport had no effect on labeling of the Golgi apparatus and mitochondria, they proposed that the transport of NBD12PS from the plasma membrane to these organelles is probably mediated by a lipid transfer protein. As shown by Table I, NBD12PS is far less hydrophobic than typical native species and can probably therefore move from the plasma membrane to mitochondria by spontaneous diffusion via the cytoplasm. Therefore, it is not necessary to invoke an involvement of a transfer protein.

These results discussed above underline the importance of considering molecular hydrophobicity when studying intracellular trafficking of PS and other lipids having access to the cytoplasmic leaflet of organelle membranes. Hydrophobicity is likely to be a relevant parameter also in other contexts, as indicated by differential sorting of short and long chain fluorescent lipid derivatives within the endosomal compartments (43).

    ACKNOWLEDGEMENTS

We are grateful to Krista Anttonen, Mirkka Koivusalo, and Perttu Haimi for assistance with various assays; Liisa Heikinheimo for critically reading the manuscript; and Tarja Grundström for skillful technical assistance.

    FOOTNOTES

* This study was supported by grants from the Finnish Academy, the University of Helsinki, the FAIR Program of the European Union, and the Sigrid Juselius Foundation.The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

Dagger To whom correspondence should be addressed. Tel.: 358-9-191-8216; Fax: 358-9-191-8276; E-mail: pentti.somerharju@helsinki.fi.

2 Tanhuanpää, Virtanen, J. A., and Somerharju, P., manuscript in preparation.

    ABBREVIATIONS

The abbreviations used are: PC, phosphatidylcholine; PE, phosphatidylethanolamine; PS, phosphatidylserine; SM, sphingomyelin; Bodipy, 4,4-difluoro-5,7-dimethyl-4-bora-3a,4a-diaza-S-indacene; Bodipy12, Bodipy-3-dodecanoylate; Bodipy12-PC, 1-hexadecanoyl,2-(4,4-difluoro-5,7-dimethyl-4-bora-3a,4a-diaza-s-indacene-3-dodecanoyl)-sn-glycero-3-PC; Bodipy12-PE, 1-hexadecanoyl,2-(4,4-difluoro-5,7-dimethyl-4-bora-3a, 4a-diaza-s-indacene-3-dodecanoyl)-sn-glycero-3-PE; Bodipy12-SM, n-(4,4-difluoro-5,7-dimethyl-4-bora-3a,4a-diaza-s-indacene-3-dodecanoyl)-SM; BP, band pass; CE-gamma -CD, carboxyethyl-gamma -cyclodextrin; NBD6PC, 2-(6-(7-nitrobenz-2-oxa-1,3-diazol-4-yl)amino)hexanoyl-1-hexadecanoyl-sn-glycero-3-PC; NBD12PS, 2-(12-(7-nitrobenz-2-oxa-1,3-diazol-4-yl)amino)dodecanoyl-1-hexadecanoyl-sn-glycero-3-PS; POPA, palmitoyl-oleoyl-phosphatidic acid; POPC, palmitoyl-oleoyl-phosphatidylcholine; PyrnPC, 16:0-pyrenylacyl-PC (n = carbons in the acyl chain); DiPyrnPC, dipyrenylacyl-PC; TNP-PE, N-trinitrophenyl-PE; I-MEM, CO2-independent medium, Life Technologies catalog number 18045; HPLC, high pressure liquid chromatography.

    REFERENCES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

1. Dennis, E. A., and Kennedy, E. P. (1972) J. Lipid. Res. 13, 263-267[Abstract]
2. Voelker, D. R. (1991) Microbiol. Rew. 55, 543-560[Abstract/Free Full Text]
3. van Meer, G., and van Genderen, I. L. (1994) Subcell. Biochem. 23, 1-24[Medline] [Order article via Infotrieve]
4. Pagano, R. E., and Sleight, R. G. (1985) Science 229, 1051-1057[Abstract/Free Full Text]
5. Rosenwald, A. G., and Pagano, R. E. (1993) Adv. Lipid Res. 26, 101-118[Medline] [Order article via Infotrieve]
6. Koval, M., and Pagano, R. E. (1991) Biochim. Biophys. Acta 1082, 113-125[Medline] [Order article via Infotrieve]
7. Hoekstra, D., and Kok, J. W. (1992) Biochim. Biophys. Acta 1113, 277-294[Medline] [Order article via Infotrieve]
8. Pagano, R. E., Longmuir, K. J., and Martin, O. C. (1983) J. Biol. Chem. 258, 2034-2040[Abstract/Free Full Text]
9. Sleight, R. G., and Pagano, R. E. (1985) J. Biol. Chem. 260, 1146-1154[Abstract/Free Full Text]
10. Sleight, R. G., and Pagano, R. E. (1984) J. Cell Biol. 99, 742-751[Abstract/Free Full Text]
11. Chattopadhyay, A., and London, E. (1987) Biochemistry 26, 39-45[CrossRef][Medline] [Order article via Infotrieve]
12. Wolf, D. E., Winiski, A. P., Ting, A. E., Bocian, K. M., and Pagano, R. E. (1992) Biochemistry 31, 2865-2873[CrossRef][Medline] [Order article via Infotrieve]
13. van Meer, G., and Simons, K. (1983) J. Cell Biol. 97, 1365-1374[Abstract/Free Full Text]
14. Kilsdonk, E. P., Yancey, P. G., Stoudt, G. W., Bangerter, F. W., Johnson, W. J., Phillips, M. C., and Rothblat, G. H. (1995) J. Biol. Chem. 270, 17250-17256[Abstract/Free Full Text]
15. Klein, U., Gimpl, G., and Fahrenholz, F. (1995) Biochemistry 34, 13784-13793[CrossRef][Medline] [Order article via Infotrieve]
16. Somerharju, P. J., van Loon, D., and Wirtz, K. W. (1987) Biochemistry 26, 7193-7199[CrossRef][Medline] [Order article via Infotrieve]
17. van Paridon, P. A., Gadella, T. W., Jr., Somerharju, P. J., and Wirtz, K. W. (1988) Biochemistry 27, 6208-6214[CrossRef][Medline] [Order article via Infotrieve]
18. Heikinheimo, L., and Somerharju, P. (1998) J. Biol. Chem. 273, 3327-3335[Abstract/Free Full Text]
19. van Amerongen, A., Demel, R. A., Westerman, J., and Wirtz, K. W. (1989) Biochim. Biophys. Acta 1004, 36-43[Medline] [Order article via Infotrieve]
20. Dix, J. A., and Verkman, A. S. (1990) Biochemistry 29, 1949-1953[CrossRef][Medline] [Order article via Infotrieve]
21. Somerharju, P., and Wirtz, K. (1982) Chem. Phys. Lipids 30, 81-91
22. Somerharju, P. J., Virtanen, J. A., Eklund, K. K., Vainio, P., and Kinnunen, P. K. (1985) Biochemistry 24, 2773-2781[CrossRef][Medline] [Order article via Infotrieve]
23. Via, D. P., Massey, J. B., Vignale, S., Kundu, S. K., Marcus, D. M., Pownall, H. J., and Gotto, A. M., Jr. (1985) Biochim. Biophys. Acta 837, 27-34[Medline] [Order article via Infotrieve]
24. Lusa, S., and Somerharju, P. (1998) Biochim. Biophys. Acta 1389, 112-122[Medline] [Order article via Infotrieve]
25. Kasurinen, J., and Somerharju, P. (1995) Biochemistry 34, 2049-2057[CrossRef][Medline] [Order article via Infotrieve]
26. Bligh, E. G., and Dyer, W. j. (1959) Can. J. Biochem. Biophys. 37, 911-917
27. Kasurinen, J., and Somerharju, P. (1992) J. Biol. Chem. 267, 6563-6569[Abstract/Free Full Text]
28. Englander, S., Calhoun, D., and Englander, J. (1987) Anal. Biochem. 161, 300-306[CrossRef][Medline] [Order article via Infotrieve]
29. Absolom, D. R. (1986) Methods Enzymol. 132, 95-180[Medline] [Order article via Infotrieve]
30. Rouser, G., Fkeischer, S., and Yamamoto, A. (1970) Lipids 5, 494-496[Medline] [Order article via Infotrieve]
31. Storrie, B., and Madden, E. A. (1990) Methods Enzymol. 182, 203-225[Medline] [Order article via Infotrieve]
32. Eklund, K. K., Virtanen, J. A., Kinnunen, P. K., Kasurinen, J., and Somerharju, P. J. (1992) Biochemistry 31, 8560-8565[CrossRef][Medline] [Order article via Infotrieve]
33. Pownall, H. J., and Smith, L. C. (1989) Chem. Phys. Lipids. 50, 191-211[CrossRef][Medline] [Order article via Infotrieve]
34. Massey, J. B., Gotto, A. M., Jr., and Pownall, H. J. (1982) J. Biol. Chem. 257, 5444-5448[Abstract/Free Full Text]
35. Jones, J. D., and Thompson, T. E. (1989) Biochemistry 28, 129-134[CrossRef][Medline] [Order article via Infotrieve]
36. McLean, L. R., and Phillips, M. C. (1981) Biochemistry 20, 2893-2900[CrossRef][Medline] [Order article via Infotrieve]
37. Han, X., and Gross, R. W. (1994) Proc. Natl. Acad. Sci. U. S. A. 91, 10635-10639[Abstract/Free Full Text]
38. Brugger, B., Erben, G., Sandhoff, R., Wieland, F. T., and Lehmann, W. D. (1997) Proc. Natl. Acad. Sci. U. S. A. 94, 2339-2344[Abstract/Free Full Text]
39. Allan, D. (1996) Mol. Membr. Biol. 13, 81-84[Medline] [Order article via Infotrieve]
40. Ohtani, Y., Irie, T., Uekama, K., Fukunaga, K., and Pitha, J. (1989) Eur. J. Biochem. 186, 17-22[Medline] [Order article via Infotrieve]
41. Pike, L. J., and Miller, J. M. (1998) J. Biol. Chem. 273, 22298-22304[Abstract/Free Full Text]
42. Furuchi, T., and Anderson, R. G. (1998) J. Biol. Chem. 273, 21099-21104[Abstract/Free Full Text]
43. Mukherjee, S., Soe, T. T., and Maxfield, F. R. (1999) J. Cell Biol. 144, 1271-1284[Abstract/Free Full Text]
44. Martin, O. C., and Pagano, R. E. (1987) J. Biol. Chem. 262, 5890-5898[Abstract/Free Full Text]
45. Kobayashi, T., and Arakawa, Y. (1991) J. Cell Biol. 113, 235-244[Abstract/Free Full Text]
46. Devaux, P. F. (1992) Ann. Rev. Biophys. Biomol. Struct. 21, 417-439[CrossRef][Medline] [Order article via Infotrieve]
47. Jasinska, R., Zborowski, J., and Somerharju, P. (1993) Biochim. Biophys. Acta 1152, 161-170[Medline] [Order article via Infotrieve]
48. Nichols, J. W. (1985) Biochemistry 24, 6390-6398[CrossRef][Medline] [Order article via Infotrieve]
49. Massey, J., Gotto, A., and Pownall, H. (1982) Biochemistry 21, 3630-3636[CrossRef][Medline] [Order article via Infotrieve]
50. Silvius, J. R. (1991) Chem. Phys. Lipids. 57, 241-252[CrossRef][Medline] [Order article via Infotrieve]
51. Keenan, T. W., and Morre, D. J. (1970) Biochemistry 9, 19-25[CrossRef][Medline] [Order article via Infotrieve]
52. van Meer, G. (1998) Trends in Cell Biology 8, 29-33[CrossRef][Medline] [Order article via Infotrieve]
53. Massey, J. B., Hickson, D., She, H. S., Sparrow, J. T., Via, D. P., Gotto, A. M., Jr., and Pownall, H. J. (1984) Biochim. Biophys. Acta 794, 274-280[Medline] [Order article via Infotrieve]


Copyright © 1999 by The American Society for Biochemistry and Molecular Biology, Inc.



This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
V. Kainu, M. Hermansson, and P. Somerharju
Electrospray Ionization Mass Spectrometry and Exogenous Heavy Isotope-labeled Lipid Species Provide Detailed Information on Aminophospholipid Acyl Chain Remodeling
J. Biol. Chem., February 8, 2008; 283(6): 3676 - 3687.
[Abstract] [Full Text] [PDF]


Home page
Mol. Biol. CellHome page
M. Koivusalo, M. Jansen, P. Somerharju, and E. Ikonen
Endocytic Trafficking of Sphingomyelin Depends on Its Acyl Chain Length
Mol. Biol. Cell, December 1, 2007; 18(12): 5113 - 5123.
[Abstract] [Full Text] [PDF]